Merck hikes revenue outlook as new drug sales grow, but cuts profit guidance due to deal charges

Merck cut its profit guidance due to a charge tied to its acquisition of biotech company Terns Pharmaceuticals.

Senast uppdaterad 5 aug. 00:05·0 artiklar i tråden